Basel Medical - BMGL Enterprise Value to EBITDA Ratio
Basel Medical Group (BMGL) operates a network of clinics in Southeast Asia, where a balanced mix of outpatient services offsets regional concentration. The asset's market valuation trend, reaching 0.00, highlights scaling constraints due to the physical limits of facilities and personnel. Meanwhile, profits are pressured by labor shortages, regulatory standards in Singapore and Hong Kong, and potential medical malpractice litigation.
Analytical breakdowns for Basel Medical Group
- market price and analyst price targets:
- issuer market value details:
- business book valuation details:
- debt obligations and liquidity statistics:
Debt to Equity Basel Medical Group|BMGL - Ratio of Long-Term Indebtedness to Capital|Short-Term Debt to Capital Basel Medical Group Ltd|BMGL - Company Cumulative Debt|Debt to Book Capitalization Ratio BMGL|BMGL - Company Long-Term Debt|Company Current Liabilities Basel Medical Group|Quick Liquidity baselmedical.com
- financial results and valuation multiples details:
BMGL - Net Income|Projected Future Earnings Basel Medical Group|BMGL - Market Cap to Earnings|Forward P/E Multiple Basel Medical Group Ltd|BMGL - Growth-Adjusted P/E Ratio|EV/EBITDA Multiple BMGL|BMGL - Operating income before deduction of amortization|Net earnings per share (EPS TTM) Basel Medical Group|BMGL - Net earnings per share for the last 12 months|Quarterly EPS earnings growth baselmedical.com|BMGL - Earnings growth in current year|Net earnings per share growth forecast for next year Basel Medical Group
Initial company analysis:BMGL (Basel Medical Group Limited)
For Basel Medical Group (BMGL), which is scaling its AI platform and billing robotics, the EV/EBITDA multiple determines the total enterprise value, including net debt, relative to operating profit before depreciation and amortization. By analyzing the EV/EBITDA chart trend for Basel Medical Group, an investor can assess the efficiency of capital expenditures in automation and the risk of excessive financial leverage during the deployment of software solutions.
Who Basel Medical Group competes with
Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization HCA Healthcare HCA|THC: Enterprise Value to Operating Income Before Depreciation|FMS: Enterprise Value to EBITDA Ratio|solventum.com - Enterprise Value to Operating Income Before Depreciation Ratio|EHC: EV/EBITDA Multiple|UHS (Universal Health Services, Inc.) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|DVA (DaVita Inc) - EV/EBITDA Multiple|EV/EBITDA Multiple RadNet Management|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Option Care Health (OPCH)|Total Company Value to Operating Income Before Depreciation Ratio surgerypartners.com|EV/EBITDA Multiple PINC (Premier)|National Vision Holdings, Inc. (EYE) - Company Value to EBITDA|PGNY - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|ARDT: Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|SEM (Select Medical) - Enterprise Value to EBITDA Ratio|astranahealth.com - Business Value to Operating Income Before Depreciation|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Pediatrix|Enterprise Value to EBITDA Ratio US Physical Therapy Inc (USPH)|EV/EBITDA Multiple PNTG|ORGO - Company Value to EBITDA|EV/EBITDA Multiple NUTX (Nutex Health Inc.)|AUNA: Enterprise Value to Operating Income Before Depreciation|SBC Medical Group - EV/EBITDA Multiple|Total Company Value to Operating Income Before Depreciation Ratio Evolus Inc EOLS|CYH: EV/EBITDA Multiple|Enterprise Value to EBITDA Ratio BeautyHealth|MDWD (MediWound Ltd) - EV/EBITDA Multiple|EV/EBITDA Multiple biote.com|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization The Joint Chiropractic (JYNT)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization DCGO (DocGo, Inc.)|P3 Health Partners - Enterprise Value to EBITDA Ratio|Business Value to Operating Income Before Depreciation GANX|EUDA Health Holdings Limited - EV/EBITDA Multiple|Enterprise Value to EBITDA Multiple CollPlant Biotechnologies (CLGN)|Cuprina Holdings (CUPR) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Concord Medical Services Holdings - Business Value to Operating Income Before Depreciation|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization American Shared Hospital Services, Inc.|Company Value to EBITDA MEDIROM Corp MRM|Enterprise Value to EBITDA Ratio ALBT (Avalon GloboCare)|EV/EBITDA Multiple dih.com (DHAI)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Carmell Therapeutics XAGE|NIVF (NewGenIvf Group) - Company Value to Operating Income Before Depreciation Ratio|ATI Physical Therapy Corp - EV/EBITDA Multiple|CMAX: Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Kindly MD, Inc. (KDLY) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Enterprise Value to EBITDA Ratio modivcare.com|NVOS (Novo Integrated Sciences, Inc.) - EV/EBITDA Multiple|SSY - Enterprise Value to EBITDA Multiple|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization IMAC Regeneration Centers (BACK)
